PLBBX
Price
$38.65
Change
+$0.30 (+0.78%)
Updated
Jul 3 closing price
Net Assets
61.52M
RLBFX
Price
$36.94
Change
+$0.18 (+0.49%)
Updated
Jul 3 closing price
Net Assets
251.2B
Interact to see
Advertisement

PLBBX vs RLBFX

Header iconPLBBX vs RLBFX Comparison
Open Charts PLBBX vs RLBFXBanner chart's image
Plumb Balanced Investor
Price$38.65
Change+$0.30 (+0.78%)
VolumeN/A
Net Assets61.52M
American Funds American Balanced R5
Price$36.94
Change+$0.18 (+0.49%)
VolumeN/A
Net Assets251.2B
PLBBX vs RLBFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PLBBX vs. RLBFX commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PLBBX is a Buy and RLBFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBFX has more cash in the bank: 251B vs. PLBBX (61.5M). RLBFX pays higher dividends than PLBBX: RLBFX (2.10) vs PLBBX (1.21). PLBBX was incepted earlier than RLBFX: PLBBX (18 years) vs RLBFX (23 years). PLBBX (1.58) is less costly to investors than RLBFX (0.29). RLBFX is a more actively managed with annual turnover of: 44.00 vs. PLBBX (26.00). RLBFX has a lower initial minimum investment than PLBBX: RLBFX (250) vs PLBBX (2500). RLBFX annual gain was more profitable for investors over the last year : 8.18 vs. PLBBX (-1.12). RLBFX return over 5 years is better than : 43.24 vs. PLBBX (15.22).
PLBBXRLBFXPLBBX / RLBFX
Total Expense Ratio1.440.29497%
Annual Report Gross Expense Ratio1.580.29545%
Fund Existence18 years23 years-
Gain YTD4.6678.22257%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets61.5M251B0%
Annual Yield % from dividends1.212.1058%
Returns for 1 year-1.128.18-14%
Returns for 3 years34.1336.1394%
Returns for 5 years15.2243.2435%
Returns for 10 years74.1968.15109%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMRK22.840.11
+0.48%
A-Mark Precious Metals
GALT2.180.01
+0.46%
Galectin Therapeutics
MKC75.15-1.41
-1.84%
McCormick & Company
CRI31.49-0.70
-2.17%
Carter's
SONN3.92-0.23
-5.54%
Sonnet BioTherapeutics Holdings Inc